JP7475397B2 - Transparent liquid cosmetics - Google Patents
Transparent liquid cosmetics Download PDFInfo
- Publication number
- JP7475397B2 JP7475397B2 JP2022097419A JP2022097419A JP7475397B2 JP 7475397 B2 JP7475397 B2 JP 7475397B2 JP 2022097419 A JP2022097419 A JP 2022097419A JP 2022097419 A JP2022097419 A JP 2022097419A JP 7475397 B2 JP7475397 B2 JP 7475397B2
- Authority
- JP
- Japan
- Prior art keywords
- test
- transparent liquid
- cosmetics
- mass
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 152
- 239000007788 liquid Substances 0.000 title claims description 71
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 44
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 44
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 42
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 33
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 33
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 33
- 229940071085 lauroyl glutamate Drugs 0.000 claims description 27
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 25
- 238000002834 transmittance Methods 0.000 claims description 20
- 238000012360 testing method Methods 0.000 description 94
- 210000000434 stratum corneum Anatomy 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 239000000203 mixture Substances 0.000 description 39
- 229940074410 trehalose Drugs 0.000 description 32
- 230000003020 moisturizing effect Effects 0.000 description 29
- 238000011156 evaluation Methods 0.000 description 23
- 239000004615 ingredient Substances 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 20
- -1 pH adjusters Substances 0.000 description 19
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 16
- 239000008213 purified water Substances 0.000 description 11
- 206010016807 Fluid retention Diseases 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000005068 transpiration Effects 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229930195712 glutamate Natural products 0.000 description 4
- 229940049906 glutamate Drugs 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 229940070765 laurate Drugs 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- GTABBGRXERZUAH-UHFFFAOYSA-N hexadecan-1-ol;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCO GTABBGRXERZUAH-UHFFFAOYSA-N 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical class CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 1
- ALVGIJJKUWXGCF-UHFFFAOYSA-N 2-[2-[2-(16-methylheptadecanoyloxy)ethoxy]ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCC(C)C ALVGIJJKUWXGCF-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000759834 Aucuba japonica Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 244000014047 Polianthes tuberosa Species 0.000 description 1
- 235000016067 Polianthes tuberosa Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940105993 dipentaerythrityl hexahydroxystearate Drugs 0.000 description 1
- XUEBMKSAZLJQFN-UHFFFAOYSA-N dipentaerythritylhexahydroxystearate Chemical compound C1C(C2)(COC(=O)C(O)(O)C(O)(O)C3(O)O)CC32C1(C1)C2(C3)CC31CC2CCCCCCCCCC XUEBMKSAZLJQFN-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940090668 parachlorophenol Drugs 0.000 description 1
- 229940072880 peg-10 stearate Drugs 0.000 description 1
- 229940032076 peg-15 glyceryl stearate Drugs 0.000 description 1
- 229940102545 peg-20 sorbitan isostearate Drugs 0.000 description 1
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、透明な液状の化粧料に関する。 The present invention relates to a transparent liquid cosmetic.
表皮の最外層に位置する角層は、水分保持機能と、水分蒸散をコントロールするバリア機能という2種類の保湿に関わる機能を有している。角層内の水分状態は、角層から蒸散して失われる水分(蒸散水分)、皮膚内部から角層に供給される水分(内部供給水分)及び外部から角層に供給される水分(外部供給水分)のバランスで決まる。 The stratum corneum, located in the outermost layer of the epidermis, has two functions related to moisture retention: a moisture retention function and a barrier function that controls moisture evaporation. The moisture state within the stratum corneum is determined by the balance of moisture lost through evaporation from the stratum corneum (evaporative moisture), moisture supplied to the stratum corneum from within the skin (internal moisture supply), and moisture supplied to the stratum corneum from the outside (external moisture supply).
しかし、冬期などの大気が乾燥して湿度が低下する環境下では、蒸散水分の量が内部供給水分及び外部供給水分の量を上回り、角層の水分が低下した状態になりやすくなる。そこで、蒸散水分の量を低減し、外部供給水分及び/又は内部供給水分の量を増やすように、角層の保湿機能を高めて、角層の水分量を維持することが求められる。 However, in environments where the air is dry and humidity is low, such as in winter, the amount of evaporated water exceeds the amount of water supplied internally and externally, making it easy for the moisture content of the stratum corneum to decrease. Therefore, it is necessary to maintain the moisture content of the stratum corneum by improving the moisturizing function of the stratum corneum, so as to reduce the amount of evaporated water and increase the amount of water supplied externally and/or internally.
角層の水分量を維持する目的では、液状化粧料がよく用いられている。外部供給水分として、及び/又は外部供給水分を外部環境から取得する役割を担い、角層内の水分を保持するように作用する保湿成分と、角層からの水分の蒸散を抑制するように作用する、及び/又は角層上部の水分を閉塞するように作用する油性エモリエント成分を含む液状化粧料により、角層の水分量を維持することが期待される。 Liquid cosmetics are often used to maintain the moisture content of the stratum corneum. Liquid cosmetics containing a moisturizing component that acts to retain moisture within the stratum corneum by supplying moisture externally and/or by acquiring moisture from the external environment, and an oil-based emollient component that acts to inhibit evaporation of moisture from the stratum corneum and/or to occlude moisture in the upper part of the stratum corneum, are expected to maintain the moisture content of the stratum corneum.
一方、我が国では、保湿機能を有する液状化粧料として、化粧水などの透明液状化粧料及び乳白色液状の乳液(クリーム)が主として用いられている。例えば、顔に適用する場合は、透明液状化粧料は洗顔後の肌にうるおいを与えるために用いられ、透明液状化粧料を使用した後、さらに肌を油分による人工膜で保護するために乳液が用いられる。このように、乳液と比べると、透明液状化粧料は、肌へのうるおいの付与を期待して、よりみずみずしい水に近い感触のものであることが求められる。また、みずみずしさやうるおいを視覚的に感じられる効果を期待して、澄明なものであることが好まれる。 Meanwhile, in Japan, the main liquid cosmetics that have moisturizing properties are transparent liquid cosmetics such as lotions and milky white liquid emulsions (creams). For example, when applied to the face, transparent liquid cosmetics are used to moisturize the skin after washing, and emulsions are used to further protect the skin with an artificial oil film after using transparent liquid cosmetics. Thus, compared to emulsions, transparent liquid cosmetics are required to have a fresh, water-like feel in the hope of moisturizing the skin. Also, clear cosmetics are preferred in the hope of providing a visual effect of freshness and moisture.
本願出願人は、これまでに数多くの液状化粧料を上市している。そのうちの一つとして、ヒアルロン酸ナトリウム、トレハロース及びラウロイルグルタミン酸ジ(コレステリル/ベヘニル/オクチルドデシル)を含む液状化粧料である「ちふれ 化粧水 ノンアルコールタイプ」を販売している(非特許文献1を参照)。また、ヒアルロン酸ナトリウム、トレハロース及びラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)を含むものとして、非特許文献2に記載の化粧料がある。 The applicant of the present application has so far marketed many liquid cosmetics. One of these is "Chifure Lotion Non-Alcohol Type," a liquid cosmetic containing sodium hyaluronate, trehalose, and di(cholesteryl/behenyl/octyldodecyl) lauroyl glutamate (see Non-Patent Document 1). In addition, there is a cosmetic described in Non-Patent Document 2 that contains sodium hyaluronate, trehalose, and di(phytosteryl/octyldodecyl) lauroyl glutamate.
非特許文献1に記載の液状化粧料は、保湿成分としてヒアルロン酸ナトリウム及びトレハロースを含むことにより、肌をみずみずしく、しっとりと保つことができる。しかし、本発明者らが調べたところによれば、非特許文献1に記載の液状化粧料は、透過率(波長660nm)が95.9%であり、やや白味がかっている。 The liquid cosmetic composition described in Non-Patent Document 1 contains sodium hyaluronate and trehalose as moisturizing ingredients, and is therefore able to keep the skin fresh and moist. However, according to the inventors' investigation, the liquid cosmetic composition described in Non-Patent Document 1 has a transmittance (wavelength 660 nm) of 95.9%, and is somewhat whitish.
非特許文献2に記載の化粧料は、非特許文献1に記載の液状化粧料と比べると透過率がやや大きいが、それでも96.7%であり十分ではない。また、非特許文献2に記載の化粧料は、粘度が高く、わずかに曵糸性を有し、水に近い感触を有するものではない。 The cosmetic composition described in Non-Patent Document 2 has a slightly higher transmittance than the liquid cosmetic composition described in Non-Patent Document 1, but it is still only 96.7%, which is not sufficient. In addition, the cosmetic composition described in Non-Patent Document 2 has a high viscosity, is slightly stringy, and does not have a texture similar to that of water.
そこで、本発明は、水に近似するほどに透過率が大きく、かつ優れた保湿機能を有する透明液状化粧料を提供することを、発明が解決しようとする課題とする。 The problem that the present invention aims to solve is to provide a transparent liquid cosmetic that has a transmittance so high that it is close to that of water, and also has excellent moisturizing properties.
本発明者らは、上記課題を解決するために、数百種類はあるとされている保湿成分について、個別に、又は組み合わせて、これらの保湿機能を検討した。そして、試行錯誤を繰り返したところ、ヒアルロン酸ナトリウム、トレハロース及びラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の3成分の組み合わせは、優れた保湿機能を発揮することを見出した。 In order to solve the above problems, the inventors have investigated the moisturizing functions of moisturizing ingredients, of which there are said to be hundreds, individually and in combination. After repeated trial and error, they have found that a combination of three ingredients, sodium hyaluronate, trehalose, and di(phytosteryl/octyldodecyl) lauroyl glutamate, exhibits excellent moisturizing functions.
驚くべきことに、上記3成分の組み合わせの保湿機能は、個々の成分の保湿機能と比べた場合、各成分の保湿機能の効果を足し合わせた相加効果というよりも、相乗効果であることがわかった。さらに驚くべきことに、このようにして調製される化粧料は、透過率が97.0%以上あり、粘度を低く設定することができることから、水に近い外観及び感触を有するものであった。 Surprisingly, it was found that the moisturizing effect of the combination of the above three ingredients is a synergistic effect rather than an additive effect of adding up the moisturizing effects of each ingredient when compared to the moisturizing effect of each ingredient individually. Even more surprising, the cosmetic material prepared in this way has a transmittance of 97.0% or more and can be set to a low viscosity, so that it has an appearance and feel close to water.
本発明者らは、上記の知見を基に、本発明の課題を解決するものとして、ヒアルロン酸ナトリウムと、トレハロースと、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)とを含み、透過率が所定の透明液状化粧料を創作することに成功した。本発明は、これらの知見及び成功例に基づき完成された発明である。 Based on the above findings, the inventors have succeeded in creating a transparent liquid cosmetic composition that contains sodium hyaluronate, trehalose, and di(phytosteryl/octyldodecyl) lauroyl glutamate and has a predetermined transmittance, in order to solve the problems of the present invention. The present invention has been completed based on these findings and successful examples.
したがって、本発明の一側面として、以下の各態様の化粧料が提供される。
[1](A)ヒアルロン酸ナトリウムと、
(B)トレハロースと、
(C)ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)と
を含み、かつ20℃での波長660nmの透過率が97.0%以上である、透明液状化粧料。
[2]前記透明液状化粧料は、前記成分(A)~(C)を、質量比([(A)+(B)]/[(C)])が0.10~3.00になるように含む、[1]に記載の透明液状化粧料。
[3]前記透明液状化粧料は、測定条件を20℃、30rpm及び1分間とする粘度が90mPa・s以下である、[1]に記載の透明液状化粧料。
[4]前記透明液状化粧料は、前記成分(A)の含有量は0.0005質量%~0.5質量%であり、前記成分(B)の含有量は0.0005質量%~0.5質量%であり、及び/又は前記成分(C)の含有量は0.01質量%~1.0質量%である、[1]~[3]のいずれか1項に記載の透明液状化粧料。
Therefore, as one aspect of the present invention, there are provided cosmetics having the following embodiments.
[1] (A) sodium hyaluronate,
(B) trehalose,
(C) A transparent liquid cosmetic preparation containing di(phytosteryl/octyldodecyl) lauroyl glutamate and having a transmittance at 20°C of 97.0% or more at a wavelength of 660 nm.
[2] The transparent liquid cosmetic preparation according to [1], wherein the transparent liquid cosmetic preparation contains the components (A) to (C) such that the mass ratio ([(A)+(B)]/[(C)]) is 0.10 to 3.00.
[3] The transparent liquid cosmetic preparation according to [1], wherein the viscosity of the transparent liquid cosmetic preparation is 90 mPa·s or less when measured under conditions of 20° C., 30 rpm, and 1 minute.
[4] The transparent liquid cosmetic preparation according to any one of [1] to [3], wherein the content of the component (A) is 0.0005% by mass to 0.5% by mass, the content of the component (B) is 0.0005% by mass to 0.5% by mass, and/or the content of the component (C) is 0.01% by mass to 1.0% by mass.
本発明の一態様の透明液状化粧料は、透過率が大きく、優れた透明性を有しながらも、持続した保湿機能を発揮し、肌をみずみずしく、しっとりと保つことができることから、例えば、毎回の洗顔後に日常的に使用することが期待される。 The transparent liquid cosmetic composition of one embodiment of the present invention has high transmittance and excellent transparency, while also exerting a sustained moisturizing function and keeping the skin fresh and moist. Therefore, it is expected to be used daily, for example, after each face wash.
以下、本発明の一態様である化粧料の詳細について説明するが、本発明はその目的を達成する限りにおいて種々の態様をとり得る。 The following describes in detail the cosmetic preparation, which is one aspect of the present invention, but the present invention can take various forms as long as it achieves its objectives.
本明細書における各用語は、別段の定めがない限り、化粧品分野における当業者により通常用いられている意味で使用され、不当に限定的な意味を有するものとして解釈されるべきではない。また、本明細書においてなされている理論や推測は、本発明者らのこれまでの知見や経験によってなされたものであることから、本発明の技術的範囲はこのような理論や推測のみによって拘泥されるものではない。 Unless otherwise specified, each term in this specification is used in the sense commonly used by those skilled in the art of cosmetics and should not be interpreted as having an unduly restrictive meaning. Furthermore, the theories and speculations made in this specification are based on the inventors' knowledge and experience to date, and therefore the technical scope of the present invention is not limited solely by such theories and speculations.
「及び/又は」は、列記した複数の関連項目のいずれか1つ、又は2つ以上の任意の組み合わせ若しくは全ての組み合わせを意味する。
「約」は、その用語に続く数量の±10%以内の量を意味する。例えば、「約100」は、100±10%、すなわち、90~110を意味する。
「含有量」は、濃度と同義であり、化粧料の全体量に対する成分の量の割合を意味する。ただし、各成分の含有量の総量は、100%を越えることはない。本明細書では、別段の定めがない限り、含有量の単位は「質量%(wt%)」を意味する。なお、成分の含有量は、市販品を用いる場合は、市販品に含まれる成分の量であることが好ましいが、市販品自体の量であってもよい。
「含む」は、含まれるものとして明示されている要素以外の要素を付加できることを意味する(「少なくとも含む」と同義である)が、「からなる」及び「から本質的になる」を包含する。すなわち、「含む」は、明示されている要素及び任意の1種若しくは2種以上の要素を含み、明示されている要素からなり、又は明示されている要素から本質的になることを意味し得る。要素としては、成分、工程、条件、パラメーターなどの制限事項などが挙げられる。
整数値の桁数と有効数字の桁数とは一致する。例えば、1の有効数字は1桁であり、10の有効数字は2桁である。また、小数値は小数点以降の桁数と有効数字の桁数とは一致する。例えば、0.1の有効数字は1桁であり、0.10の有効数字は2桁である。
"And/or" means any one or any or all combinations of two or more of the associated listed items.
"About" means an amount within ±10% of the quantity following the term. For example, "about 100" means 100 ±10%, i.e., from 90 to 110.
"Content" is synonymous with concentration and refers to the ratio of the amount of a component to the total amount of a cosmetic. However, the total amount of each component does not exceed 100%. In this specification, unless otherwise specified, the unit of content means "mass % (wt%)". When a commercially available product is used, the content of the component is preferably the amount of the component contained in the commercially available product, but may be the amount of the commercially available product itself.
"Comprising" means that elements other than the elements explicitly stated as being included can be added (same meaning as "comprising at least"), but also encompasses "consisting of" and "consisting essentially of." That is, "comprising" can mean including the elements explicitly stated and any one or more elements, consisting of the elements explicitly stated, or consisting essentially of the elements explicitly stated. Elements include limitations such as ingredients, steps, conditions, and parameters.
The number of digits in an integer value is the same as the number of significant digits. For example, 1 has one significant digit, and 10 has two significant digits. Also, the number of digits after the decimal point in a decimal value is the same as the number of significant digits. For example, 0.1 has one significant digit, and 0.10 has two significant digits.
本発明の一態様の透明液状化粧料は、ヒアルロン酸ナトリウム(以下、成分(A)ともよぶ)と、トレハロース(以下、成分(B)ともよぶ)と、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)(以下、成分(C)ともよぶ)とを含む。さらに、本発明の一態様の透明液状化粧料は、これらの成分(A)~(C)を含みつつも、20℃での波長660nmの透過率が97.0%以上であることを特徴とする。 The transparent liquid cosmetic composition of one embodiment of the present invention contains sodium hyaluronate (hereinafter also referred to as component (A)), trehalose (hereinafter also referred to as component (B)), and di(phytosteryl/octyldodecyl) lauroyl glutamate (hereinafter also referred to as component (C)). Furthermore, the transparent liquid cosmetic composition of one embodiment of the present invention is characterized in that, while containing these components (A) to (C), it has a transmittance of 97.0% or more at a wavelength of 660 nm at 20°C.
成分(A)であるヒアルロン酸ナトリウムは、水溶性ムコ多糖類の一種であり、保湿剤などとして化粧料に用いられる。ヒアルロン酸ナトリウムは、その分子量が化粧料の粘度に与える可能性がある。すなわち、分子量が大きいヒアルロン酸ナトリウムを含む化粧料は、閉塞性が高くなり、皮膚表面に留まる傾向にあるが、粘度が大きくなる傾向にある。そこで、ヒアルロン酸ナトリウムの分子量(GPC)の上限は、約300万ダルトンであることが好ましく、200万ダルトンであることがより好ましい。ヒアルロン酸ナトリウムの分子量(GPC)の下限は、典型的には0.5万ダルトンである。なお、ヒアルロン酸ナトリウムの分子量は、本発明の一態様の透明液状化粧料に付与する粘度、ヒアルロン酸ナトリウムの含有量などによって適宜設定することができる。 Sodium hyaluronate, which is component (A), is a type of water-soluble mucopolysaccharide and is used in cosmetics as a moisturizer. The molecular weight of sodium hyaluronate may affect the viscosity of the cosmetic. That is, cosmetics containing sodium hyaluronate with a large molecular weight tend to have high occlusiveness and remain on the skin surface, but tend to have high viscosity. Therefore, the upper limit of the molecular weight (GPC) of sodium hyaluronate is preferably about 3 million daltons, more preferably 2 million daltons. The lower limit of the molecular weight (GPC) of sodium hyaluronate is typically 5,000 daltons. The molecular weight of sodium hyaluronate can be appropriately set depending on the viscosity imparted to the transparent liquid cosmetic of one embodiment of the present invention, the content of sodium hyaluronate, and the like.
ヒアルロン酸ナトリウムの取得方法は特に限定されず、例えば、鶏冠、皮膚、軟骨組織といった動物組織から常法により抽出及び精製する方法、微生物醗酵によって取得する方法、市販品を購入する方法などが挙げられる。ヒアルロン酸ナトリウムの市販品としては、例えば、「BIO-SODIUM HYALURONATE POWDER」シリーズのグレード「HMW」、「MMW」、「LMW」、「VLMW」(いずれもHYUNDAI BIOLAND社製)、ヒアルロン酸「FCH-200」、「FCH-150」、「FCH-120」、「FCH-80」、「FCH-60」、「FCH-SU」(キッコーマンバイオケミファ社製)、「ヒアルロンサンHA-LQ」、「ヒアルロンサンHA-LQH」、「HAbooster(登録商標)」(キユーピー社製)、「PrimalHyaltm(登録商標) Ultrafiller」「ヒアルロン酸ナトリウム末」(ホルス社製)などが挙げられる。ヒアルロン酸ナトリウムは、加水分解したヒアルロン酸ナトリウムや、一部の置換基がアセチル化したヒアルロン酸ナトリウムであってもよい。ヒアルロン酸ナトリウムは上記したものの1種を単独で、又は2種以上組み合わせて使用してもよい。 There are no particular limitations on the method for obtaining sodium hyaluronate, and examples of such methods include extraction and purification from animal tissues such as cockscomb, skin, and cartilage tissue using conventional methods, obtaining it through microbial fermentation, and purchasing it as a commercially available product. Examples of commercially available sodium hyaluronate include the grades "HMW", "MMW", "LMW" and "VLMW" of the "BIO-SODIUM HYALURONATE POWDER" series (all manufactured by HYUNDAI BIOLAND), hyaluronic acid "FCH-200", "FCH-150", "FCH-120", "FCH-80", "FCH-60" and "FCH-SU" (manufactured by Kikkoman Biochemifa Corporation), "Hyaluronic Acid HA-LQ", "Hyaluronic Acid HA-LQH", "HAbooster (registered trademark)" (manufactured by Kewpie Corporation), "PrimalHyaltm (registered trademark) Ultrafiller" and "Sodium hyaluronate powder" (manufactured by Horus Co., Ltd.). Sodium hyaluronate may be hydrolyzed sodium hyaluronate or sodium hyaluronate in which some of the substituents have been acetylated. The sodium hyaluronate may be used alone or in combination of two or more of the above.
成分(B)であるトレハロースは、グルコースが1,1-グリコシド結合してなる二糖である。トレハロースの取得方法は特に限定されず、例えば、酵母発酵によって取得する方法、でん粉などの植物材料から取得する方法、化学的に合成する方法、市販品を購入する方法などが挙げられる。トレハロースの市販品としては、例えば、「トレハロース(化粧品用)」(林原社製)などが挙げられる。 Trehalose, component (B), is a disaccharide formed by 1,1-glycosidic bonds between glucose. There are no particular limitations on the method for obtaining trehalose, and examples of such methods include obtaining it by yeast fermentation, obtaining it from plant materials such as starch, chemical synthesis, and purchasing it as a commercially available product. An example of a commercially available trehalose product is "Trehalose (for cosmetics)" (manufactured by Hayashibara Co., Ltd.).
成分(C)であるラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)は、L-グルタミン酸、ラウリン酸、高級アルコール及びフィトステロールからなるアミノ酸系油剤である。ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の取得方法は特に限定されず、例えば、化学的に合成する方法、市販品を購入する方法などが挙げられる。ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の市販品としては、例えば、「エルデュウ(登録商標)PS-203」(味の素社製)、「Plandool(登録商標)-LG2」(日本精化社製)などが挙げられる。 Component (C), di-(phytosteryl/octyldodecyl) lauroyl glutamate, is an amino acid-based oil agent consisting of L-glutamic acid, lauric acid, higher alcohol, and phytosterol. There are no particular limitations on the method for obtaining di-(phytosteryl/octyldodecyl) lauroyl glutamate, and examples of such methods include chemical synthesis and purchasing a commercially available product. Commercially available products of di-(phytosteryl/octyldodecyl) lauroyl glutamate include, for example, "ELDEW (registered trademark) PS-203" (manufactured by Ajinomoto Co., Inc.) and "Plandool (registered trademark)-LG2" (manufactured by Nippon Fine Chemicals Co., Ltd.).
本発明の一態様の透明液状化粧料は、成分(A)~(C)を含むことにより、持続した保湿機能を発揮することができる。さらに、本発明の一態様の透明液状化粧料は、成分(A)~(C)の含有量が所定の関係にあることにより、より優れた閉塞性を示し得る。この観点から、本発明の一態様の透明液状化粧料は、成分(A)~(C)を、質量比([(A)+(B)]/[(C)])が0.10~3.00になるように含むことが好ましく、0.20~2.60になるように含むことがより好ましく、0.30~1.75になるように含むことがなおさらに好ましい。 The transparent liquid cosmetic composition of one embodiment of the present invention is able to exert a sustained moisturizing function by containing components (A) to (C). Furthermore, the transparent liquid cosmetic composition of one embodiment of the present invention is able to exhibit superior occlusive properties by having the contents of components (A) to (C) in a specific relationship. From this viewpoint, the transparent liquid cosmetic composition of one embodiment of the present invention preferably contains components (A) to (C) such that the mass ratio ([(A)+(B)]/[(C)]) is 0.10 to 3.00, more preferably 0.20 to 2.60, and even more preferably 0.30 to 1.75.
成分(A)、成分(B)及び成分(C)のそれぞれの含有量は、上記質量比になるような量にすることが好ましい。例えば、本発明の一態様の透明液状化粧料の透明性、粘度、安定性などを考慮すれば、成分(A)の含有量は、0.0005質量%~0.5質量%であることが好ましく、0.001質量%~0.5質量%であることがより好ましく、0.01質量%~0.1質量%であることがさらに好ましく;成分(B)の含有量は、0.0005質量%~0.5質量%であることが好ましく、0.001質量%~0.5質量%であることがより好ましく、0.01質量%~0.3質量%であることがさらに好ましく;成分(C)の含有量は、0.01質量%~1.0質量%であることが好ましく、0.02質量%~0.8質量%であることがより好ましく、0.03質量%~0.6質量%であることがさらに好ましい。 The contents of components (A), (B) and (C) are preferably adjusted to the above-mentioned mass ratio. For example, taking into consideration the transparency, viscosity, stability and the like of the transparent liquid cosmetic of one embodiment of the present invention, the content of component (A) is preferably 0.0005% to 0.5% by mass, more preferably 0.001% to 0.5% by mass, and even more preferably 0.01% to 0.1% by mass; the content of component (B) is preferably 0.0005% to 0.5% by mass, more preferably 0.001% to 0.5% by mass, and even more preferably 0.01% to 0.3% by mass; and the content of component (C) is preferably 0.01% to 1.0% by mass, more preferably 0.02% to 0.8% by mass, and even more preferably 0.03% to 0.6% by mass.
本発明の一態様の透明液状化粧料は、成分(A)~(C)を含みつつも、優れた透明性を有する。本発明の一態様の透明液状化粧料の透明性は、20℃での波長660nmの透過率が97.0%以上である透明性であればよいが、より透明性のあるものとするために、上記透過率は好ましくは98.0%以上であり、より好ましくは99.0%以上である。本発明の一態様の透明液状化粧料は、含有する成分によって色づけされてもよいが、無色又は微白色であることが好ましい。 The transparent liquid cosmetic composition of one embodiment of the present invention has excellent transparency while containing components (A) to (C). The transparency of the transparent liquid cosmetic composition of one embodiment of the present invention may be such that the transmittance at a wavelength of 660 nm at 20°C is 97.0% or more, but in order to achieve even greater transparency, the transmittance is preferably 98.0% or more, and more preferably 99.0% or more. The transparent liquid cosmetic composition of one embodiment of the present invention may be colored by the components contained therein, but is preferably colorless or pale white.
本発明の一態様の透明液状化粧料は、水のような感触を有するものとするためには、粘度が低いことが好ましい。このような場合、本発明の一態様の透明液状化粧料は、測定条件を20℃、30rpm及び1分間として測定される粘度が90mPa・s以下であることが好ましく、50mPa・s以下であることがより好ましく、20mPa・s以下であることがさらに好ましく、10mPa・s以下又は5.0mPa・s以下であることがなおさらに好ましい。なお、上記粘度の下限は、典型的には0.1mPa・sである。 The transparent liquid cosmetic composition of one embodiment of the present invention preferably has a low viscosity so as to have a water-like feel. In such a case, the transparent liquid cosmetic composition of one embodiment of the present invention preferably has a viscosity of 90 mPa·s or less, more preferably 50 mPa·s or less, even more preferably 20 mPa·s or less, and even more preferably 10 mPa·s or less or 5.0 mPa·s or less, measured under measurement conditions of 20°C, 30 rpm, and 1 minute. The lower limit of the viscosity is typically 0.1 mPa·s.
本発明の一態様の透明液状化粧料の透過率及び粘度は、後述する実施例に記載されている方法によって測定して得られる値である。 The transmittance and viscosity of the transparent liquid cosmetic of one embodiment of the present invention are values obtained by measuring using the method described in the Examples below.
本発明の一態様の透明液状化粧料は、優れた透明性を有し、かつ優れた保湿機能を発揮するものである限り、成分(A)~(C)に加えて、その他の成分を含んでもよい。 The transparent liquid cosmetic composition of one embodiment of the present invention may contain other ingredients in addition to the ingredients (A) to (C), so long as it has excellent transparency and exhibits excellent moisturizing properties.
その他の成分は特に限定されず、例えば、通常の液状化粧料に用いられる成分などが挙げられ、より具体的には水、油剤、保湿剤、防腐剤、pH調整剤、乳化剤、酸化防止剤、清涼剤、キレート剤、美容成分、その他各種薬効成分、粉体、香料、色材などが挙げられる。その他の成分の含有量は、本発明の課題解決を妨げない限り、当業者により適宜設定し得る。その他の成分の幾つかについて以下に列挙するが、これらはあくまでも例示であり、限定されるものではない。 The other components are not particularly limited, and examples include components used in ordinary liquid cosmetics, more specifically water, oils, moisturizers, preservatives, pH adjusters, emulsifiers, antioxidants, cooling agents, chelating agents, cosmetic ingredients, various other medicinal ingredients, powders, fragrances, coloring materials, etc. The content of the other components can be appropriately set by a person skilled in the art as long as it does not interfere with the solution of the problems of the present invention. Some of the other components are listed below, but these are merely examples and are not limiting.
水は、化粧料の製造に際して使用される水であればよく、精製水、イオン交換水、水道水などが挙げられる。水の含有量は、70質量%~90質量%であることが好ましく、80質量%~90質量%であることがより好ましい。 The water may be any water used in the production of cosmetics, such as purified water, ion-exchanged water, and tap water. The water content is preferably 70% to 90% by mass, and more preferably 80% to 90% by mass.
油剤としては、例えば、油性エモリエント成分などが挙げられ、具体的にはトリエチルヘキサノイン、イソノナン酸イソノニル、イソノナン酸イソトリデシル、リンゴ酸ジイソステアリル、パルミチン酸エチルヘキシル、エチルヘキサン酸セチル、ヘキサヒドロキシステアリン酸ジペンタエリスリチル、テトライソステアリン酸ペンタエリスリチル、ダイマージリノール酸ダイマージリノレイルビス(ベヘニル/イソステアリル/フィトステリル)、ステアリルアルコール、セテアリルアルコール、ベヘニルアルコール、ジメチコン、シクロペンタシロキサン、メチルフェニルポリシロキサン、ジフェニルシロキシフェニルトリメチコン、スクワラン、ミネラルオイル、水添ポリ(C6-12オレフィン)、メトキシケイヒ酸エチルヘキシル、トリイソステアリン酸ポリグリセリル-2、オリーブ果実油、ホホバ種子油、ラベンダー油、月見草油、アボガド油、ツバキ種子油、マカデミア種子油などが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。油剤の含有量は、0質量%~1.5質量%であることが好ましく、0質量%~0.6質量%であることがより好ましい。 Examples of oils include oil-based emollient components, specifically triethylhexanoin, isononyl isononanoate, isotridecyl isononanoate, diisostearyl malate, ethylhexyl palmitate, cetyl ethylhexanoate, dipentaerythrityl hexahydroxystearate, pentaerythrityl tetraisostearate, dimer dilinoleyl bis(behenyl/isostearyl/phytosteryl) dimer dilinoleate, stearyl alcohol, cetearyl alcohol, etc. Examples of the oils include choline, behenyl alcohol, dimethicone, cyclopentasiloxane, methylphenyl polysiloxane, diphenylsiloxyphenyl trimethicone, squalane, mineral oil, hydrogenated poly(C6-12 olefin), ethylhexyl methoxycinnamate, polyglyceryl-2 triisostearate, olive fruit oil, jojoba seed oil, lavender oil, evening primrose oil, avocado oil, camellia seed oil, and macadamia seed oil. These oils may be used alone or in combination of two or more. The content of the oil is preferably 0% to 1.5% by mass, and more preferably 0% to 0.6% by mass.
保湿剤としては、例えば、グリセリン、ブチレングリコール(BG)、プロピレングリコール(PG)、ジグリセリン、ジプロピレングリコール(DPG)、メチルグルセス-10、メチルグルセス-20、PEG/PPG/ポリブチレングリコール-8/5/3グリセリン、キシリトール、マルチトール、マルトース、ソルビトール、イノシトール、エリスリトール、ブドウ糖、果糖、加水分解エラスチン、乳酸ナトリウム、シクロデキストリン、ピロリドンカルボン酸、尿素などが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。保湿剤の含有量は、0質量%~30質量%であることが好ましいが、本発明の一態様の透明液状化粧料により優れた保湿機能を付与するためには、5質量%~25質量%であることがより好ましく、10質量%~20質量%であることがさらに好ましい。 Examples of moisturizing agents include glycerin, butylene glycol (BG), propylene glycol (PG), diglycerin, dipropylene glycol (DPG), methyl gluceth-10, methyl gluceth-20, PEG/PPG/polybutylene glycol-8/5/3 glycerin, xylitol, maltitol, maltose, sorbitol, inositol, erythritol, glucose, fructose, hydrolyzed elastin, sodium lactate, cyclodextrin, pyrrolidone carboxylic acid, and urea. These may be used alone or in combination of two or more. The content of the moisturizing agent is preferably 0% to 30% by mass, but in order to impart a superior moisturizing function to the transparent liquid cosmetic composition of one embodiment of the present invention, it is more preferable that the content is 5% to 25% by mass, and even more preferable that the content is 10% to 20% by mass.
防腐剤としては、例えば、パラオキシ安息香酸エステル(メチルパラベン、プロピルパラベンなど)及びそのナトリウム塩、フェノキシエタノール、安息香酸、安息香酸塩類、サリチル酸、サリチル酸塩類、ソルビン酸及びその塩類、クロルフェネシン、ヒノキチオール、イソプロピルメチルフェノール、パラクロルフェノール、塩化ベンザルコニウム、塩酸クロルヘキシジン、トリクロロカルバニリド、感光素などが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。防腐剤の含有量は、0質量%~1質量%であることが好ましい。 Examples of preservatives include paraoxybenzoic acid esters (methylparaben, propylparaben, etc.) and their sodium salts, phenoxyethanol, benzoic acid, benzoates, salicylic acid, salicylates, sorbic acid and its salts, chlorphenesin, hinokitiol, isopropylmethylphenol, parachlorophenol, benzalkonium chloride, chlorhexidine hydrochloride, trichlorocarbanilide, photosensitizers, etc., and these can be used alone or in combination of two or more. The content of the preservative is preferably 0% to 1% by mass.
pH調整剤としては、例えば、乳酸、クエン酸、クエン酸ナトリウム、グリコール酸、コハク酸、酒石酸、リンゴ酸、リンゴ酸ナトリウム、エチドロン酸、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム、水酸化ナトリウム、水酸化カリウム、アルギニン、トリエタノールアミン、モノエタノールアミンなどが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。pH調整剤の含有量は、0質量%~1質量%であることが好ましい。pH調整剤は中和剤ともよぶ。 Examples of pH adjusters include lactic acid, citric acid, sodium citrate, glycolic acid, succinic acid, tartaric acid, malic acid, sodium malate, etidronic acid, potassium carbonate, sodium bicarbonate, ammonium bicarbonate, sodium hydroxide, potassium hydroxide, arginine, triethanolamine, and monoethanolamine. These can be used alone or in combination of two or more. The content of the pH adjuster is preferably 0% to 1% by mass. The pH adjuster is also called a neutralizing agent.
乳化剤としては、例えば、親油性乳化剤、親水性乳化剤などが挙げられ、具体的には、ステアリン酸グリセリル(SE)などのグリセリン脂肪酸エステル;ラウリン酸ポリグリセリル-6、ミリスチン酸ポリグリセリル-10、ステアリン酸ポリグリセリル-10、イソステアリン酸ポリグリセリル-10などのポリグリセリン脂肪酸エステル;ステアリン酸PEG-5グリセリル、ステアリン酸PEG-15グリセリル、イソステアリン酸PEG-15グリセリル、トリイソステアリン酸PEG-20グリセリル、オレイン酸PEG-5グリセリルなどのポリオキシエチレングリセリン脂肪酸エステル;ヤシ脂肪酸ソルビタン、オレイン酸ソルビタン、セスキオレイン酸ソルビタン、パルミチン酸ソルビタンなどのソルビタン脂肪酸エステル;ポリソルベート40、ポリソルベート60、ポリソルベート80、イソステアリン酸PEG-20ソルビタンなどのポリオキシエチレンソルビタン脂肪酸エステル;ラウリン酸ソルベス-6、テトラオレイン酸ソルベス-6、テトラオレイン酸ソルベス-30、テトラオレイン酸ソルベス-60などのポリオキシエチレンソルビット脂肪酸エステル;PEG-20水添ヒマシ油、PEG-30水添ヒマシ油、PEG-60水添ヒマシ油、トリイソステアリン酸PEG-50水添ヒマシ油などのポリオキシエチレン硬化ヒマシ油;ポリオキシエチレンセチルエーテル(セテス-20)、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンベヘニルエーテルなどのポリオキシエチレンアルキルエーテル;PPG-4セテス-1、PPG-8セテス-20、PPG-6デシルテトラデセス-12、PPG-6デシルテトラデセス-20などのポリオキシエチレンポリオキシプロピレンアルキルエーテル;ラウリン酸PEG-10、ステアリン酸PEG-10、ステアリン酸PEG-25、ステアリン酸PEG-40、ステアリン酸PEG-45、ステアリン酸PEG-55、オレイン酸PEG-10、ジステアリン酸PEG-150、ジイソステアリン酸PEG-8などのポリエチレングリコール脂肪酸エステル;水添レシチン、水添リゾレシチンなどのレシチン誘導体などが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。乳化剤の含有量は、0質量%~5質量%であることが好ましい。 Examples of emulsifiers include lipophilic emulsifiers and hydrophilic emulsifiers. Specific examples of emulsifiers include glycerin fatty acid esters such as glyceryl stearate (SE); polyglycerin fatty acid esters such as polyglyceryl-6 laurate, polyglyceryl-10 myristate, polyglyceryl-10 stearate, and polyglyceryl-10 isostearate; PEG-5 glyceryl stearate, PEG-15 glyceryl stearate, PEG-15 glyceryl isostearate, PEG-20 glyceryl triisostearate, and PEG-10 oleate. sorbitan fatty acid esters such as sorbitan coconutate, sorbitan oleate, sorbitan sesquioleate, and sorbitan palmitate; polyoxyethylene sorbitan fatty acid esters such as polysorbate 40, polysorbate 60, polysorbate 80, and PEG-20 sorbitan isostearate; polyoxyethylene sorbitan fatty acid esters such as sorbeth-6 laurate, sorbeth-6 tetraoleate, sorbeth-30 tetraoleate, and sorbeth-60 tetraoleate; fatty acid esters; polyoxyethylene hydrogenated castor oils such as PEG-20 hydrogenated castor oil, PEG-30 hydrogenated castor oil, PEG-60 hydrogenated castor oil, and PEG-50 hydrogenated castor oil triisostearate; polyoxyethylene alkyl ethers such as polyoxyethylene cetyl ether (ceteth-20), polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, and polyoxyethylene behenyl ether; PPG-4 ceteth-1, PPG-8 ceteth-20, PPG-6 decyltetradeceth-12, and PPG-6 decyltetradeceth-20; Examples of the emulsifier include polyoxyethylene polyoxypropylene alkyl ethers such as Ladeceth-20; polyethylene glycol fatty acid esters such as PEG-10 laurate, PEG-10 stearate, PEG-25 stearate, PEG-40 stearate, PEG-45 stearate, PEG-55 stearate, PEG-10 oleate, PEG-150 distearate, and PEG-8 diisostearate; and lecithin derivatives such as hydrogenated lecithin and hydrogenated lysolecithin. These may be used alone or in combination of two or more. The content of the emulsifier is preferably 0% by mass to 5% by mass.
酸化防止剤としては、例えば、ジブチルヒドロキシトルエン(BHT)、ブチルヒドロキシアニソール(BHA)、トコフェロールなどのビタミンE及びその誘導体;チオタウリン、メマツヨイグサ抽出液、βカロチン、カテキン化合物、フラボノイド化合物、ポリフェノール化合物、ピロ亜硫酸ナトリウムなどが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。酸化防止剤の含有量は、0質量%~1質量%であることが好ましい。 Examples of antioxidants include vitamin E and its derivatives, such as dibutylhydroxytoluene (BHT), butylhydroxyanisole (BHA), and tocopherol; thiotaurine, evening primrose extract, β-carotene, catechin compounds, flavonoid compounds, polyphenol compounds, and sodium pyrosulfite; these can be used alone or in combination of two or more. The content of the antioxidant is preferably 0% to 1% by mass.
キレート剤としては、例えば、アラニン、エデト酸2ナトリウム(EDTA-2Na)、ポリリン酸ナトリウム、メタリン酸ナトリウム、フィチン酸ナトリウム、リン酸3ナトリウム、グルコン酸ナトリウムなどが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。キレート剤の含有量は、0質量%~0.1質量%程度が好ましい。 Examples of chelating agents include alanine, disodium edetate (EDTA-2Na), sodium polyphosphate, sodium metaphosphate, sodium phytate, trisodium phosphate, and sodium gluconate. These can be used alone or in combination of two or more. The content of the chelating agent is preferably about 0% to 0.1% by mass.
美容成分としては、例えば、リンゴタンニン(リンゴ果実エキス)、カンゾウ根エキス、レスベラトロール、チューベロース多糖体、異性化糖、ヤエヤマアオキ果汁、チンピエキス、グリチルリチン酸ジカリウムなどが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。美容成分の含有量は、0質量%~5質量%であることが好ましい。 Examples of beauty ingredients include apple tannin (apple fruit extract), licorice root extract, resveratrol, tuberose polysaccharide, isomerized sugar, Japanese laurel juice, chinpi extract, and dipotassium glycyrrhizinate. These can be used alone or in combination of two or more. The content of the beauty ingredient is preferably 0% to 5% by mass.
薬効成分としては、例えば、アスコルビン酸とその塩及び誘導体、アラントイン、ニコチン酸アミド、ハイドロキノンとその配糖体、トラネキサム酸、コウジ酸、並びに「いわゆる薬用化粧品中の有効成分リスト」に記載されたものなどが挙げられ、これらの1種を単独で、又は2種以上を組み合わせて使用できる。薬効成分の含有量は、0質量%~5質量%であることが好ましい。 Examples of medicinal ingredients include ascorbic acid and its salts and derivatives, allantoin, nicotinamide, hydroquinone and its glycosides, tranexamic acid, kojic acid, and those listed in the "List of Active Ingredients in Medicinal Cosmetics." These can be used alone or in combination of two or more. The content of the medicinal ingredient is preferably 0% to 5% by mass.
本発明の一態様の透明液状化粧料は、化粧料として用いられる限りにおいて、その機能及び/又は効果については特に限定されない。本発明の一態様の透明液状化粧料は、優れた保湿機能を発揮する。本発明の一態様の透明液状化粧料の保湿機能は、例えば、後述する実施例に記載の閉塞性、抱水性、保水性及び角層水分量により評価することができる。 The function and/or effect of the transparent liquid cosmetic composition of one embodiment of the present invention is not particularly limited, so long as it is used as a cosmetic composition. The transparent liquid cosmetic composition of one embodiment of the present invention exhibits excellent moisturizing function. The moisturizing function of the transparent liquid cosmetic composition of one embodiment of the present invention can be evaluated, for example, by the occlusive property, water holding ability, water retention ability, and stratum corneum moisture content described in the Examples below.
本発明の一態様の透明液状化粧料は、成分(A)及び成分(B)を含み、成分(C)を含まず、かつその他の成分はほぼ同様である透明液状化粧料に比べて、又は成分(C)を含み、成分(A)及び成分(B)を含まず、かつその他の成分はほぼ同様である透明液状化粧料に比べて、閉塞性及び/又は角層水分量が優れている。 The transparent liquid cosmetic preparation according to one embodiment of the present invention has superior occlusive properties and/or stratum corneum moisture content compared to a transparent liquid cosmetic preparation that contains component (A) and component (B) but does not contain component (C) and that has substantially similar other ingredients, or compared to a transparent liquid cosmetic preparation that contains component (C) but does not contain components (A) and (B) and that has substantially similar other ingredients.
本発明の一態様の透明液状化粧料の製造方法は特に限定されず、水溶性の成分と水とを混合して水相を形成し、親油性の成分を混合して油相を形成し、次いで水相を撹拌しながら油相を徐々に加えて、全体的に均質になるように混合することなどにより製造することができる。これらの工程において、適宜加温してもよい。加温する際の温度は特に限定されないが、例えば、65℃~85℃である。 The method for producing the transparent liquid cosmetic of one embodiment of the present invention is not particularly limited, and it can be produced by mixing a water-soluble component with water to form an aqueous phase, mixing a lipophilic component to form an oil phase, and then gradually adding the oil phase while stirring the aqueous phase, and mixing until the entire mixture is homogeneous. In these steps, heating may be performed as appropriate. The temperature during heating is not particularly limited, but is, for example, 65°C to 85°C.
本発明の一態様の透明液状化粧料は、その使用態様や剤形については特に限定されず、例えば、化粧水、美容液といったスキンケア化粧料などに適用可能である。また、本発明の一態様の透明液状化粧料は、シートなどに含浸すること、噴射することなどが可能である。そこで、本発明の一態様の透明液状化粧料は、含浸シート、含浸マスク、ポンプなどのスプレーといった剤形とすることが期待される。 The transparent liquid cosmetic composition of one embodiment of the present invention is not particularly limited in its mode of use or formulation, and can be used, for example, in skin care cosmetics such as lotions and serums. The transparent liquid cosmetic composition of one embodiment of the present invention can be impregnated into sheets or sprayed. It is therefore expected that the transparent liquid cosmetic composition of one embodiment of the present invention will be in the form of an impregnated sheet, an impregnated mask, or a spray pump.
本発明の一態様の透明液状化粧料は、水のような感触でありながら、皮膚に塗布することで、角層の水分量を向上し、及び/又は皮膚からの水分の蒸散を抑制して、持続した優れた保湿機能を発揮し、肌をみずみずしく、しっとりと保つことができる。 The transparent liquid cosmetic of one embodiment of the present invention has a water-like feel, but when applied to the skin, it increases the moisture content of the stratum corneum and/or inhibits evaporation of moisture from the skin, exerting a sustained and excellent moisturizing function and keeping the skin fresh and moist.
以下、本発明を実施例によってさらに具体的に説明するが、本発明はこれら実施例に限定されるものではなく、本発明の課題を解決し得る限り、本発明は種々の態様をとることができる。 The present invention will be explained in more detail below with reference to examples, but the present invention is not limited to these examples, and the present invention can take various forms as long as the problem of the present invention can be solved.
<例1 3成分の保湿性評価>
[1-1 被験試料の調製]
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)として、「エルデュウ(登録商標)PS-203」(味の素社製)を用いた。ヒアルロン酸ナトリウムとして、「BIO-SODIUM HYALURONATE POWDER(MMW)」(HYUNDAI BIOLAND社製)(分子量が1.5MDa(GPC))を用いた。トレハロースとして、「トレハロース(化粧品用)」(林原社製)を用いた。
Example 1: Evaluation of moisturizing properties of three ingredients
[1-1 Preparation of test sample]
As the di(phytosteryl/octyldodecyl) lauroyl glutamate, "ELDEW (registered trademark) PS-203" (manufactured by Ajinomoto Co., Ltd.) was used. As the sodium hyaluronate, "BIO-SODIUM HYALURONATE POWDER (MMW)" (manufactured by HYUNDAI BIOLAND Co., Ltd.) (molecular weight: 1.5 MDa (GPC)) was used. As the trehalose, "Trehalose (for cosmetics)" (manufactured by Hayashibara Co., Ltd.) was used.
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)のみを被験試料1とした。2質量%ヒアルロン酸ナトリウム及び20質量%トレハロースの水溶液を被験試料2として用いた。 Di(phytosteryl/octyldodecyl) lauroyl glutamate alone was used as test sample 1. An aqueous solution of 2% by mass sodium hyaluronate and 20% by mass trehalose was used as test sample 2.
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースを、市販品として10:1:3の質量比で混合したものを被験試料3として用いた。 A mixture of commercially available di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate, and trehalose in a mass ratio of 10:1:3 was used as test sample 3.
[1-2 評価方法]
(1-2-1)閉塞性
被験試料 50mgを均一に塗布したろ紙を、精製水 15gが入った規格ビン(PS-7K)の口に載せて、室温で静置した。ろ紙を取り除いた状態で、試験前及び24時間経過後のビンの重量を測定した。コントロールとして、被験試料を塗布していないろ紙を用いて、同様に測定した。以下の式により各被験試料の蒸散抑制率を求め、閉塞性を評価した(繰り返し数は3)。
被験試料の蒸散抑制率(%)=[T0-T24]/[t0-t24]×100
T0:被験試料を用いた場合の、試験前のビンの重量
T24:被験試料を用いた場合の、24時間経過後のビンの重量
t0:コントロールを用いた場合の、試験前のビンの重量
t24:コントロール用いた場合の、24時間経過後のビンの重量
[1-2 Evaluation Method]
(1-2-1) Occlusivity A filter paper with 50 mg of test sample evenly applied was placed on the mouth of a standard bottle (PS-7K) containing 15 g of purified water and allowed to stand at room temperature. With the filter paper removed, the weight of the bottle was measured before the test and after 24 hours had passed. As a control, a filter paper without the test sample applied was used and similarly measured. The transpiration inhibition rate of each test sample was calculated using the following formula to evaluate occlusion (repeated 3 times).
Evaporation inhibition rate (%) of test sample = [T 0 - T 24 ]/[t 0 - t 24 ] x 100
T 0 : Weight of the bottle before the test when the test sample was used T 24 : Weight of the bottle after 24 hours when the test sample was used t 0 : Weight of the bottle before the test when the control was used t 24 : Weight of the bottle after 24 hours when the control was used
(1-2-2)抱水性
被験試料1及び3について、乳鉢に被験試料 10gを量り取り、精製水 0.4gを滴下しながら乳棒を用いて手動で撹拌して、被験試料と精製水とをよく混じり合わせた。均一に混合後、さらに精製水 0.4gを滴下して同様に撹拌及び混合した。これを繰り返して、被験試料と精製水とが混じり合わなくなり、目視で水が分離するようになった時点を終点とした。以下の式により、抱水率を求め、抱水性を評価した(繰り返し数は3)。
抱水率(%)=[終点前までの滴下した精製水の総量]/[被験試料の量]×100
(1-2-2) Water Holding Capacity For test samples 1 and 3, 10 g of the test sample was weighed out into a mortar, and 0.4 g of purified water was added dropwise while stirring manually with a pestle to thoroughly mix the test sample and purified water. After uniform mixing, 0.4 g of purified water was added dropwise and stirred and mixed in the same manner. This was repeated until the test sample and purified water could no longer be mixed and the water was visually separated, which was the end point. The water holding capacity was evaluated by calculating the water holding capacity according to the following formula (repeated 3 times).
Water holding rate (%) = [total amount of purified water dropped before the end point] / [amount of test sample] × 100
(1-2-3)保水性
被験試料1及び3については、抱水性を試験したときに得られた終点における被験試料及び精製水の混合液(最大量抱水している状態)をサンプルとして用いた。被験試料2は、それ自体をサンプルとして用いた。
(1-2-3) Water Retention Capacity For test samples 1 and 3, a mixture of the test sample and purified water at the end point (maximum water retention state) obtained when testing water retention capacity was used as a sample. For test sample 2, it was used as a sample by itself.
サンプルを改めてよく混合した後、2gを規格ビン(PS-7K)に量り取り、蓋をせずに、シリカゲルが入ったデシケーター内で24時間静置した。試験前及び24時間経過後のビンの重量を測定して、試験前のビンの重量に対する24時間経過後のビンの重量を百分率で示すことにより保水率(水分変化率)を求め、保水性を評価した。 After thoroughly mixing the sample again, 2 g was weighed into a standard bottle (PS-7K) and left uncapped in a desiccator containing silica gel for 24 hours. The weight of the bottle was measured before and after 24 hours had passed, and the water retention rate (moisture change rate) was calculated by expressing the weight of the bottle after 24 hours as a percentage of the weight of the bottle before the test, and the water retention was evaluated.
[1-3 評価結果]
被験試料1~3について、閉塞性、抱水性及び保水性を評価した結果を図1~3に示す。
[1-3 Evaluation results]
The test samples 1 to 3 were evaluated for occlusion property, water holding property and water retention property, and the results are shown in FIGS.
図1が示すとおり、被験試料3は、被験試料1よりもラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の含有量が少なく、さらに閉塞性が認められなかったヒアルロン酸ナトリウム及びトレハロースを含むものでありながら、閉塞性は被験試料1と同程度であった。そして、抱水性については、被験試料1よりもむしろ、被験試料3の方が良好であった。保水性についても、被験試料3と被験試料1との間に大きな差異は認められなかった。 As shown in Figure 1, Test Sample 3 contained less di(phytosteryl/octyldodecyl) lauroyl glutamate than Test Sample 1, and further contained sodium hyaluronate and trehalose, which did not show occlusive properties, yet had the same level of occlusive properties as Test Sample 1. Furthermore, Test Sample 3 had better water holding ability than Test Sample 1. There was also no significant difference in water retention between Test Sample 3 and Test Sample 1.
以上の結果から、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースの3成分の組み合わせにより、相乗的な効果として閉塞性、抱水性及び保水性が発揮されたことがわかった。 These results show that the combination of the three ingredients di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate, and trehalose exerts a synergistic effect in terms of occlusion, water holding, and water retention.
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)は油分であるため、水に溶け難く、水に混ぜるときは撹拌しながらゆっくりと添加する。しかし、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)に加えて、水溶性であるヒアルロン酸ナトリウム及びトレハロースを用いることにより、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の含有量を低減しながらも、同等又はそれ以上の閉塞性、抱水性及び保水性を化粧料に付与することができれば、水性の化粧料の製造工程において、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)を可溶化し易くなり、分離の懸念が少なくなって、化粧料の製造効率が向上するという利点がある。 Since dilauroyl glutamate (phytosteryl/octyldodecyl) is an oil, it is difficult to dissolve in water, and when mixed with water, it is added slowly while stirring. However, if water-soluble sodium hyaluronate and trehalose are used in addition to dilauroyl glutamate (phytosteryl/octyldodecyl), the content of dilauroyl glutamate (phytosteryl/octyldodecyl) can be reduced while imparting the same or greater occlusiveness, water-holding property, and water-retentive property to the cosmetic, this has the advantage that dilauroyl glutamate (phytosteryl/octyldodecyl) can be easily solubilized in the manufacturing process of aqueous cosmetics, reducing concerns about separation and improving the manufacturing efficiency of the cosmetic.
<例2 透明液状化粧料の短期保湿性評価(1)>
[2-1 被験化粧料の調製]
表1に示した処方に従い、以下の手順により、透明液状化粧料として各種被験化粧料を調製した。なお、表中の数値「%」は、質量%(wt%)を表わす。
Example 2: Evaluation of short-term moisturizing properties of transparent liquid cosmetics (1)
[2-1 Preparation of test cosmetics]
Various test cosmetics were prepared as transparent liquid cosmetics by the following procedure according to the formulations shown in Table 1. Note that the numerical values "%" in the table indicate mass % (wt %).
ヒアルロン酸ナトリウム、トレハロース、メチルパラベン及び水を混合したもの(水相)を、メチルパラベンが均一溶解するように75℃まで加温した。また、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)とPPG-8セテス-20とを均一に混合したもの(油相)を、水相との温度差をなくすために75℃まで加温した。パドルを用いて緩やかに水相を撹拌(回転数180rpm)しながら、油相を加えていき、均一に混合した。攪拌を続けながら30℃まで徐冷することにより、実施例1の被験化粧料を得た。なお、比較例1~3の被験化粧料は、ヒアルロン酸ナトリウム、トレハロース及び/又はラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)を配合せずに、同様の方法により調製した。 A mixture of sodium hyaluronate, trehalose, methylparaben and water (aqueous phase) was heated to 75°C so that methylparaben was uniformly dissolved. A uniform mixture of di(phytosteryl/octyldodecyl) lauroyl glutamate and PPG-8 ceteth-20 (oil phase) was heated to 75°C to eliminate the temperature difference with the aqueous phase. The aqueous phase was gently stirred (180 rpm) with a paddle while the oil phase was added and mixed uniformly. The mixture was gradually cooled to 30°C while continuing to stir, to obtain the test cosmetic of Example 1. The test cosmetics of Comparative Examples 1 to 3 were prepared in the same manner, but without sodium hyaluronate, trehalose and/or di(phytosteryl/octyldodecyl) lauroyl glutamate.
[2-2 評価方法]
(2-2-1)角層水分量(短期)
無作為に選んだパネラー12名を対象として、温度22℃、湿度50%に温湿度を設定した肌測定室内にて、20分間馴化(待機)した後、塗布量が1mg/cm2になるように被験化粧料(実施例1、比較例1~3)を直接的に前腕内側部の皮膚へ塗布した。各塗布部位について、皮膚計測器「Corneometer CM825」(COURAGE-KHAZAKA electronic GmbH社製)を用いて、角層水分量を塗布前と、塗布後10分ごとに2時間測定した。ひとつの被験化粧料塗布部について、4箇所測定した。塗布前(0分:無塗布)における角層水分量に対する、一定時間経過時の角層水分量との差を、変化量(ΔAU)としてそれぞれ求めた。プラトー時(塗布後、測定値の減少程度が落ち着いた時間)における測定結果について、対応のあるt検定にて統計解析を行った。
[2-2 Evaluation Method]
(2-2-1) Moisture content of the stratum corneum (short term)
Twelve randomly selected panelists were allowed to acclimate (standby) for 20 minutes in a skin measurement room set at a temperature of 22°C and humidity of 50%, and then the test cosmetics (Example 1, Comparative Examples 1 to 3) were directly applied to the skin of the inner forearm at an application amount of 1 mg/ cm2 . For each application site, the stratum corneum moisture content was measured before application and every 10 minutes after application for 2 hours using a skin measuring device "Corneometer CM825" (manufactured by COURAGE-KHAZAKA electronic GmbH). Measurements were made at four locations for each application site of the test cosmetics. The difference between the stratum corneum moisture content before application (0 minutes: no application) and the stratum corneum moisture content after a certain time period was calculated as the change (ΔAU). Statistical analysis was performed using a paired t-test on the measurement results at the plateau (the time when the degree of decrease in the measured value settled after application).
[2-3 評価結果]
(2-3-1)角層水分量(短期)
実施例1及び比較例1~3の被験化粧料について、短期角層水分量の経時変化を示したグラフを図4に示し、塗布後10分、70分及び120分の短期角層水分量の変化量を示したグラフを図5に示す。
[2-3 Evaluation Results]
(2-3-1) Moisture content of the stratum corneum (short term)
FIG. 4 is a graph showing the change in short-term stratum corneum moisture content over time for the test cosmetics of Example 1 and Comparative Examples 1 to 3, and FIG. 5 is a graph showing the change in short-term stratum corneum moisture content 10 minutes, 70 minutes, and 120 minutes after application.
図4及び図5が示すとおり、実施例1の被験化粧料は、比較例1~3の被験化粧料に対して、いずれの時間においても角層水分量が高かった。また、実施例1の被験化粧料について、塗布後70分及び120分の間ではほとんど差異がみられなかった。これは比較例2の被験化粧料(エルデュウのみ含有)についても同様であった。しかし、比較例3の被験化粧料(ヒアルロン酸ナトリウム及びトレハロースを含有)は塗布後120分の角層水分量は塗布後70分の角層水分量よりも少なかった。 As shown in Figures 4 and 5, the test cosmetic of Example 1 had a higher stratum corneum moisture content at all times compared to the test cosmetics of Comparative Examples 1 to 3. Furthermore, for the test cosmetic of Example 1, almost no difference was observed between 70 and 120 minutes after application. This was also the case for the test cosmetic of Comparative Example 2 (containing only Eldew). However, for the test cosmetic of Comparative Example 3 (containing sodium hyaluronate and trehalose), the stratum corneum moisture content 120 minutes after application was lower than the stratum corneum moisture content 70 minutes after application.
実施例1の被験化粧料は、ヒアルロン酸ナトリウム及びトレハロースを含有しているのにもかかわらず、塗布後70分及び120分の角層水分量にほとんど差異がみられなかったという結果は、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースの3成分の組み合わせによる角層の水分保持効果は、各成分による相加的な効果というよりも、相乗的な効果であることがわかった。 Although the test cosmetic of Example 1 contained sodium hyaluronate and trehalose, there was almost no difference in the moisture content of the stratum corneum 70 minutes and 120 minutes after application. This result indicates that the moisture retention effect of the combination of the three ingredients di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate, and trehalose on the stratum corneum is a synergistic effect rather than an additive effect of each ingredient.
また、比較例2及び比較例3の被験化粧料を比較すると、塗布後10分では比較例3の被験化粧料の方が角層水分量は多く、塗布後70分では比較例2の被験化粧料の方が角層水分量は多かった。この結果から、塗布後比較的短期間では、ヒアルロン酸ナトリウム及びトレハロースの有する抱水性がラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の有する抱水性及び閉塞性を上回り、ヒアルロン酸ナトリウム及びトレハロースによる保湿機能が発揮されることがわかった。また、塗布後時間が経つにつれて、ヒアルロン酸ナトリウム及びトレハロースの有する抱水性よりも、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の有する閉塞性により角層水分量の減少が抑制されることがわかった。そして、3成分が組み合わさることにより、ヒアルロン酸ナトリウム及びトレハロースの有する抱水性、並びにラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の有する抱水性及び閉塞性が相乗的に発揮して、長期間の角層水分量の保持が達成されると推測される。 In addition, when the test cosmetics of Comparative Example 2 and Comparative Example 3 were compared, the test cosmetic of Comparative Example 3 had a higher stratum corneum moisture content 10 minutes after application, and the test cosmetic of Comparative Example 2 had a higher stratum corneum moisture content 70 minutes after application. From these results, it was found that in a relatively short period after application, the water holding capacity of sodium hyaluronate and trehalose exceeded the water holding capacity and occlusive capacity of di(phytosteryl/octyldodecyl) lauroyl glutamate, and the moisturizing function of sodium hyaluronate and trehalose was exerted. It was also found that as time passed after application, the decrease in stratum corneum moisture content was suppressed more by the occlusive capacity of di(phytosteryl/octyldodecyl) lauroyl glutamate than by the water holding capacity of sodium hyaluronate and trehalose. It is believed that the combination of these three ingredients synergistically exerts the water-holding properties of sodium hyaluronate and trehalose, and the water-holding and occlusive properties of di(phytosteryl/octyldodecyl) lauroyl glutamate, helping to maintain moisture in the stratum corneum for a long period of time.
<例3 透明液状化粧料の閉塞性評価>
[3-1 被験化粧料の調製]
表2に示した処方に従い、上記2-1と同様の手順により、透明液状化粧料として各種被験化粧料を調製した。なお、表中の数値「%」は、質量%(wt%)を表わす。
Example 3: Evaluation of Occlusion Properties of Transparent Liquid Cosmetics
[3-1 Preparation of test cosmetics]
Various test cosmetics were prepared as transparent liquid cosmetics in the same manner as in 2-1 above, according to the formulations shown in Table 2. The numerical values "%" in the table indicate mass % (wt %).
[3-2 評価方法]
(3-2-1)閉塞性
上記1-2-1と同様にして、閉塞性を評価した(繰り返し数は3)。ただし、求めた被験化粧料の蒸散抑制率について、比較例1とその他の被験化粧料との比較をわかりやすくするために、各被験化粧料の蒸散抑制率から比較例1の蒸散抑制率を差し引いた値を求めた。
[3-2 Evaluation Method]
(3-2-1) Occlusivity The occlusion property was evaluated in the same manner as in 1-2-1 above (repeated 3 times). However, in order to make it easier to compare the transpiration inhibition ratios of the test cosmetic preparations obtained in Comparative Example 1 with the other test cosmetic preparations, the transpiration inhibition ratios of the test cosmetic preparations were calculated by subtracting the transpiration inhibition ratio of Comparative Example 1 from the transpiration inhibition ratio of each test cosmetic preparation.
[3-3 評価結果]
(3-3-1)閉塞性
実施例2~4、比較例1~3、参考例1~2の被験化粧料について、閉塞性の評価結果を図6に示す。なお、3成分比とは、[ヒアルロン酸ナトリウム及びトレハロースの総含有量]/[ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の含有量]を示す。
[3-3 Evaluation Results]
(3-3-1) Occlusion Property The evaluation results of occlusion property for the test cosmetics of Examples 2 to 4, Comparative Examples 1 to 3, and Reference Examples 1 and 2 are shown in Fig. 6. The ratio of the three components indicates [total content of sodium hyaluronate and trehalose]/[content of di(phytosteryl/octyldodecyl) lauroyl glutamate].
図1~3の結果から、油剤であるラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)の含有量が多い(3成分比が小さい)ほど、閉塞性が高くなると推測していた。しかし、実際には、図6が示すとおり、3成分比の順番で参考例1、実施例2~4及び参考例2の結果を並べた場合、実施例3(3成分比 1.00)を最大値とする正規分布様になることがわかった。 From the results in Figures 1 to 3, it was assumed that the higher the content of the oil di(phytosteryl/octyldodecyl) lauroyl glutamate (the smaller the three-component ratio), the higher the occlusiveness. However, in reality, as shown in Figure 6, when the results of Reference Example 1, Examples 2 to 4, and Reference Example 2 are arranged in order of the three-component ratio, it was found that the results show a normal distribution with Example 3 (three-component ratio 1.00) as the maximum value.
以上の結果から、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)とヒアルロン酸ナトリウム及びトレハロースとを、特定の割合で配合することによって、閉塞性(水分蒸散抑制効果)が向上することがわかった。 These results show that by combining di(phytosteryl/octyldodecyl) lauroyl glutamate with sodium hyaluronate and trehalose in a specific ratio, occlusiveness (moisture evaporation inhibition effect) is improved.
<例4 透明液状化粧料の短期保湿性評価(2)>
[4-1 被験化粧料の調製]
表3に示した処方に従い、以下の手順により、透明液状化粧料として各種被験化粧料を調製した。なお、表中の数値「%」は、質量%(wt%)を表わす。
Example 4: Evaluation of short-term moisturizing properties of transparent liquid cosmetic preparations (2)
[4-1 Preparation of test cosmetics]
Various test cosmetics were prepared as transparent liquid cosmetics by the following procedure according to the formulations shown in Table 3. Note that the numerical values "%" in the table indicate mass % (wt %).
成分(1)、(2)、(4)~(7)、(13)、(14)及び(16)を均一混合したもの(水相)を、メチルパラベンが均一溶解するように75℃まで加温した。また、成分(3)、(8)~(12)及び(15)を均一に混合したもの(油相)を、水相との温度差をなくすために75℃まで加温した。パドルを用いて緩やかに水相を撹拌(回転数180rpm)しながら、油相を加えていき、均一になるまで混合した。攪拌を続けながら30℃まで徐冷することにより、各被験化粧料を得た。 A homogeneous mixture of ingredients (1), (2), (4) to (7), (13), (14), and (16) (aqueous phase) was heated to 75°C so that methylparaben was uniformly dissolved. A homogeneous mixture of ingredients (3), (8) to (12), and (15) (oil phase) was heated to 75°C to eliminate the temperature difference with the aqueous phase. While gently stirring the aqueous phase with a paddle (rotation speed 180 rpm), the oil phase was added and mixed until homogeneous. Each test cosmetic was obtained by gradually cooling to 30°C while continuing to stir.
[4-2 評価方法]
(4-2-1)角層水分量(短期)
無作為に選んだパネラー7名を対象として、被験化粧料(実施例5~6)及び水(精製水)を用い、上記2-2-1と同様に角層水分量の変化量(ΔAU)を求めた。
[4-2 Evaluation Method]
(4-2-1) Moisture content of the stratum corneum (short term)
Seven randomly selected panelists were asked to determine the change in stratum corneum moisture content (ΔAU) using the test cosmetics (Examples 5-6) and water (purified water) in the same manner as in 2-2-1 above.
[4-3 評価結果]
(4-3-1)角層水分量(短期)
実施例5~6の被験化粧料及び精製水について、短期角層水分量の経時変化を示したグラフを図7に示す。
[4-3 Evaluation Results]
(4-3-1) Moisture content of the stratum corneum (short term)
FIG. 7 is a graph showing the change over time in short-term stratum corneum moisture content for the test cosmetics of Examples 5 and 6 and purified water.
図7が示すとおり、実施例5~6の被験化粧料は、図4に示す実施例1の被験化粧料と同様に、角層水分保持作用を有することがわかった。 As shown in Figure 7, the test cosmetics of Examples 5 and 6 were found to have the same moisture-retaining effect on the stratum corneum as the test cosmetic of Example 1 shown in Figure 4.
<例5 透明液状化粧料の長期保湿性評価>
[5-1 評価方法]
(5-1-1)角層水分量(長期)
無作為に選んだパネラー21名(30代~50代、女性)を対象として、1日2回、2週間、半顔に実施例5の被験化粧料を塗布させ、もう一方の半顔には比較例4の被験化粧料を塗布させた。なお、パネラーには化粧料がいずれのものであるのかは知らせなかった(ブラインドテスト)。塗布前及び塗布後2週間の両側の頬について、上記2-2-1 と同様に角層水分量を測定した。それぞれの被験化粧料における塗布後2週間の角層水分量について、塗布前の角層水分量を100%としたときの相対値を求めた。
Example 5: Evaluation of long-term moisturizing properties of transparent liquid cosmetic materials
[5-1 Evaluation Method]
(5-1-1) Moisture content of the stratum corneum (long-term)
Twenty-one randomly selected panelists (women in their 30s to 50s) were asked to apply the test cosmetic of Example 5 to one half of their face twice a day for two weeks, and the test cosmetic of Comparative Example 4 to the other half of their face. The panelists were not informed of which cosmetic was used (blind test). The moisture content of the stratum corneum was measured on both cheeks before and two weeks after application in the same manner as in 2-2-1 above. The relative value of the moisture content of the stratum corneum two weeks after application of each test cosmetic was calculated, assuming that the moisture content of the stratum corneum before application was 100%.
[5-2 評価結果]
(5-2-1)角層水分量(長期)
実施例5及び比較例4の被験化粧料について、角層水分量(長期)を測定した結果を図8に示す。
[5-2 Evaluation Results]
(5-2-1) Moisture content of the stratum corneum (long-term)
The results of measuring the moisture content of the stratum corneum (long term) for the test cosmetics of Example 5 and Comparative Example 4 are shown in FIG.
図8に示すとおり、実施例5の被験化粧料の相対値は約102%であり、ほとんど変化しなかった比較例4の被験化粧料よりも大きかった。これにより、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースの3成分を含む化粧料は、2週間塗布し続けた場合にでも、優れた保湿機能を発揮することがわかった。なお、実施例5の被験化粧料は、塗布後4週間でも角層の水分量保持効果が維持された。 As shown in Figure 8, the relative value for the test cosmetic of Example 5 was approximately 102%, which was greater than that of the test cosmetic of Comparative Example 4, which showed almost no change. This demonstrates that the cosmetic containing the three components di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate, and trehalose exhibits excellent moisturizing function even when applied continuously for two weeks. The test cosmetic of Example 5 maintained its moisture retention effect in the stratum corneum even four weeks after application.
<例6 透明液状化粧料の透過率及び粘度評価>
[6-1 評価方法]
(6-1-1)透過率
第十八改正日本薬局方の「一般試験法 2.61 濁度試験法」に準じて、紫外線可視分光光度計(「UV-1900」;島津製作所社製)を用いて、20℃の被験化粧料について、波長660nmの透過率を測定した(繰り返し回数は3回)。セルは、「アズラボ標準石英セル Q-244」(アズワン社製)を用いた。
Example 6: Evaluation of transmittance and viscosity of transparent liquid cosmetic preparations
[6-1 Evaluation Method]
(6-1-1) Transmittance According to "General Test Method 2.61 Turbidity Test Method" of the 18th Edition of the Japanese Pharmacopoeia, the transmittance of the test cosmetic at a wavelength of 660 nm was measured (repeated three times) at 20°C using an ultraviolet-visible spectrophotometer ("UV-1900"; manufactured by Shimadzu Corporation). The cell used was "ASLAB Standard Quartz Cell Q-244" (manufactured by AS ONE Corporation).
(6-1-2)粘度
B型粘度計(「VISCOMETER TVB-25L」;東機産業社製)及びロータ(「L/Adp」;東機産業社製)を使用した。測定条件は、20℃の被験化粧料について、30rpm、1分間とした。
(6-1-2) Viscosity A Brookfield viscometer ("VISCOMETER TVB-25L" manufactured by Toki Sangyo Co., Ltd.) and a rotor ("L/Adp" manufactured by Toki Sangyo Co., Ltd.) were used. The measurement conditions were 30 rpm, 1 minute for the test cosmetic material at 20°C.
[6-2 評価結果]
実施例5~6の被験化粧料、参考例3の被験化粧料(非特許文献1に記載の「ちふれ 化粧水 ノンアルコールタイプ」)及び参考例4の被験化粧料(非特許文献2に記載の「ドクターシーラボ VC100エッセンスローションEXスペシャル」)について、透過率及び粘度を測定した結果を表4に示す。
[6-2 Evaluation Results]
The transmittance and viscosity were measured for the test cosmetics of Examples 5 and 6, the test cosmetic of Reference Example 3 ("Chifure Non-alcoholic Lotion" described in Non-Patent Document 1), and the test cosmetic of Reference Example 4 ("Dr. Ci:Labo VC100 Essence Lotion EX Special" described in Non-Patent Document 2), and the results are shown in Table 4.
透過率について、表4に示すとおり、実施例5~6の被験化粧料は、透過率が99%以上であり、無色澄明な液体であった。それに対して、参考例3及び4の被験化粧料は、透過率が97%以下であった。また、実施例5~6の被験化粧料について、参考例4の被験化粧料に対して対応のないt検定にて統計解析したところ、いずれもp<0.001となり、有意差が認められた。 As shown in Table 4, the test cosmetics of Examples 5 to 6 had a transmittance of 99% or more and were colorless, clear liquids. In contrast, the test cosmetics of Reference Examples 3 and 4 had a transmittance of 97% or less. Furthermore, when the test cosmetics of Examples 5 to 6 were statistically analyzed against the test cosmetic of Reference Example 4 using an unpaired t-test, the results were all p<0.001, indicating a significant difference.
粘度について、表4に示すとおり、実施例5~6及び参考例3の被験化粧料は、粘度が5mPa・s以下であった。それに対して、参考例4の被験化粧料の粘度は約100mPa・sであり、比較的粘性の感じられるものであった。なお、参考例4の被験化粧料は、回転数により粘度が異なる値となり、非ニュートン流体であると考えられた。 As for viscosity, as shown in Table 4, the test cosmetics of Examples 5-6 and Reference Example 3 had a viscosity of 5 mPa·s or less. In contrast, the test cosmetic of Reference Example 4 had a viscosity of approximately 100 mPa·s, which felt relatively viscous. The test cosmetic of Reference Example 4 had a viscosity value that varied depending on the rotation speed, and was considered to be a non-Newtonian fluid.
以上の結果より、実施例5~6の被験化粧料は、透過率が99%以上であることから澄明であり、さらに粘度が5mPa・s以下であることから水に近い感触のする透明液状化粧料であることがわかった。 These results show that the test cosmetics of Examples 5 and 6 are clear because they have a transmittance of 99% or more, and because they have a viscosity of 5 mPa·s or less, they are transparent liquid cosmetics that feel similar to water.
また、例1~例6の結果から、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースの3成分を所定の割合で含む透明液状化粧料は、澄明かつ水に近い感触でありながら、優れた保湿機能を発揮するものであることがわかった。 In addition, the results of Examples 1 to 6 show that a transparent liquid cosmetic containing three components, di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate, and trehalose, in a specified ratio is clear and feels similar to water, while also exhibiting excellent moisturizing properties.
実施例5~6の被験化粧料と同様にして、表5~7に示す実施例7~9の被験化粧料を製造した。実施例7~9の被験化粧料は、実施例5~6の被験化粧料と同程度の透過率及び粘度を有するものであった。 The test cosmetics of Examples 7 to 9 shown in Tables 5 to 7 were produced in the same manner as the test cosmetics of Examples 5 to 6. The test cosmetics of Examples 7 to 9 had the same transmittance and viscosity as the test cosmetics of Examples 5 to 6.
本発明の一態様の透明液状化粧料は、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、ヒアルロン酸ナトリウム及びトレハロースの3成分による相乗的な閉塞性、抱水性及び保水性を発揮して、優れた保湿効果を奏しつつも、水に近似するような透明性及び感触を呈し得ることから、化粧水、含浸シート、含浸マスク、スプレーなどのスキンケア化粧品などとして利用することができる。使用者は、本発明の一態様の透明液状化粧料を使用することにより、日常的に快適に、肌の乾燥を低減又は防止することが期待できる。 The transparent liquid cosmetic composition of one embodiment of the present invention exerts synergistic occlusiveness, water-holding and water-retentive properties due to the three components of di(phytosteryl/octyldodecyl) lauroyl glutamate, sodium hyaluronate and trehalose, and while it has an excellent moisturizing effect, it can also exhibit transparency and a feel similar to that of water, and therefore can be used as skin care cosmetics such as lotions, impregnated sheets, impregnated masks and sprays. By using the transparent liquid cosmetic composition of one embodiment of the present invention, users can expect to reduce or prevent dry skin in a comfortable manner on a daily basis.
Claims (3)
(B)トレハロースと、
(C)ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)と
を含み、かつ20℃での波長660nmの透過率が97.0%以上である、透明液状化粧料であって、
前記成分(C)の含有量は0.01質量%~0.6質量%であり、及び
前記成分(A)~(C)を、質量比([(A)+(B)]/[(C)])が0.10~3.00になるように含む、前記透明液状化粧料。 (A) sodium hyaluronate,
(B) trehalose,
(C) di(phytosteryl/octyldodecyl) lauroyl glutamate, and a transparent liquid cosmetic preparation having a transmittance at 20°C of 97.0% or more at a wavelength of 660 nm ,
The content of the component (C) is 0.01% by mass to 0.6% by mass, and
The transparent liquid cosmetic preparation comprises the components (A) to (C) such that the mass ratio ([(A)+(B)]/[(C)]) is 0.10 to 3.00.
The transparent liquid cosmetic preparation according to any one of claims 1 to 2, wherein the content of the component (A) in the transparent liquid cosmetic preparation is 0.0005% by mass to 0.5% by mass, and/or the content of the component (B) in the transparent liquid cosmetic preparation is 0.0005% by mass to 0.5 % by mass.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022097419A JP7475397B2 (en) | 2022-06-16 | 2022-06-16 | Transparent liquid cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022097419A JP7475397B2 (en) | 2022-06-16 | 2022-06-16 | Transparent liquid cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023183746A JP2023183746A (en) | 2023-12-28 |
| JP7475397B2 true JP7475397B2 (en) | 2024-04-26 |
Family
ID=89333912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022097419A Active JP7475397B2 (en) | 2022-06-16 | 2022-06-16 | Transparent liquid cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7475397B2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019019077A (en) | 2017-07-18 | 2019-02-07 | ポーラ化成工業株式会社 | Skin external composition |
| JP2020158398A (en) | 2019-03-25 | 2020-10-01 | 日本精化株式会社 | Cosmetic containing isosorbide derivative |
-
2022
- 2022-06-16 JP JP2022097419A patent/JP7475397B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019019077A (en) | 2017-07-18 | 2019-02-07 | ポーラ化成工業株式会社 | Skin external composition |
| JP2020158398A (en) | 2019-03-25 | 2020-10-01 | 日本精化株式会社 | Cosmetic containing isosorbide derivative |
Non-Patent Citations (2)
| Title |
|---|
| Chifure,Moisturizing Lotion deep Moist, DATABASE GNPD [ONLINE], MINTEL, 2022年8月, [令和5年11月16日検索], ID 9804304, インターネット<http://www.gnpd.com> |
| Shiseido,All In One Lotion, DATABASE GNPD [ONLINE], MINTEL, 2021年9月, [令和5年11月16日検索], ID 9014544, インターネット<http://www.gnpd.com> |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023183746A (en) | 2023-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4786630B2 (en) | Topical skin preparation | |
| HU230156B1 (en) | Preparation of an agent containing onion extract and fatty oil for the treatment, prevention or treatment of damaged skin tissue, in particular scars | |
| CN102665650A (en) | Cosmetic composition stabilized higher oily part | |
| KR102359729B1 (en) | Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation | |
| KR20100050477A (en) | Alkylene oxide derivative and skin external preparation containing the same | |
| JP7608217B2 (en) | Composition for topical application to the skin | |
| KR20170086126A (en) | Cosmetic emulsions | |
| US10493013B2 (en) | Liquid skin-conditioning composition | |
| JP2005060234A (en) | External preparation for skin | |
| JP2024076194A (en) | Skin preparations | |
| JP2005060233A (en) | External preparation for skin | |
| AU2013232729A1 (en) | Cosmetic composition | |
| JP7475397B2 (en) | Transparent liquid cosmetics | |
| JP7778337B2 (en) | oil-in-water emulsion | |
| JP6783512B2 (en) | Topical skin agent | |
| TW202308591A (en) | Cosmetic | |
| JP7546113B1 (en) | Oil-in-water emulsion cosmetics | |
| JP7732911B2 (en) | Skin cosmetic composition | |
| JP7795986B2 (en) | Cleansing cosmetics | |
| JP6783511B2 (en) | Topical skin agent | |
| JP7091282B2 (en) | Gel-like cosmetics | |
| JP2024078236A (en) | Crystallization inhibitor | |
| JP2026025992A (en) | Oil-in-water sunscreen cosmetics | |
| JP2020002042A (en) | Oral composition | |
| JP2024003819A (en) | skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221011 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231205 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240201 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240402 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240416 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7475397 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |